- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-03-0007569

Ambia Pharma Private Limited
About Ambia Pharma Private Limited
Data last updated:
Ambia Pharma Private Limited is a private limited company based in Delhi, India. It operates in the other human health activities segment of the healthcare sector. It was incorporated on 18 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85190DL2021PTC381231. Its GSTIN is 07AAVCA2332H1ZM (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Azhar Ali and Sumaiyya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 44/3 Ground Floor Near Okhla Industrial Area Ph – II, Delhi, India – 110020.
Ambia Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0007569).
Company details
Recognitions & Rankings of Ambia Pharma
Contact details
Ambia Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressE – 44/3 Ground Floor Near Okhla Industrial Area Ph – II, Delhi, India – 110020
- IndustryHealthcare, Other Human Health Activities, Human Health Activities
To see the full contact details of Ambia Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Ambia Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Ambia Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ambia Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ambia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ambia Pharma Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
GST
Ambia Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAVCA2332H1ZM | Delhi | Active | 28 Jun 2021 |
To see the full GST registrations and return filing status of Ambia Pharma Private Limited, buy the company report.
Recent activity
Ambia Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Azhar Ali was appointed as Director on 18 May 2021.
Frequently asked questions
Ambia Pharma is an active private limited company based in Delhi, India. The company works in other human health activities, within the healthcare industry. It was incorporated on 18 May 2021 (5+ years old) and is registered under CIN U85190DL2021PTC381231.
The latest financial statements of Ambia Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Ambia Pharma is 07AAVCA2332H1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Ambia Pharma is U85190DL2021PTC381231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambia Pharma was incorporated on 18 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Azhar Ali was appointed as Director on 18 May 2021. Sumaiyya was appointed as Director on 18 May 2021.
Yes, Ambia Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0007569).
The registered office of Ambia Pharma is at E – 443 Ground Floor Near Okhla Industrial Area Ph – II, Delhi, India – 110020.
Ambia Pharma operates in the healthcare industry, in the other human health activities segment.

